In this study, we found that the expression levels of markers of PCa EMT and bone metastasis also changed after inhibiting TNIK using NCB-0846, demonstrating the therapeutic potential of TNIK-targeted therapy in PCa. Here, TNIK is linked to posterior cortical atrophy.